Analysis
SpaceX shares traded below their $135 IPO price for the first time since the company's public debut, CNBC reported July 15, a notable early test for one of the most closely watched listings in recent market history.
SpaceX's 2026 IPO priced at a valuation reportedly north of $1.7 trillion, built on the strength of Starlink's subscriber growth, Starship's reusability progress and the company's dominant share of US government launch contracts; the $135 issue price itself represented a compromise between bullish pre-IPO secondary marks and more conservative institutional roadshow demand.
SpaceX now trades alongside a thin field of publicly listed aerospace and defense-adjacent names, including Rocket Lab at the smaller end and legacy primes like Lockheed Martin and Northrop Grumman on the traditional side, none of which commands SpaceX's growth multiple -- which is part of why a break below issue price draws outsized market attention relative to the actual percentage decline involved.
For the late-stage funds and SPVs that built SpaceX positions in the secondary and pre-IPO market at marks above $135, the current public trade is now the reference price LPs will use to judge those positions in year-end reporting, a live reminder that a marquee logo doesn't guarantee a markup once public price discovery takes over from private negotiated marks.
The bear case: SpaceX's underlying operating metrics -- launch cadence, Starlink growth, government contract backlog -- haven't visibly deteriorated, and the stock's decline appears more tied to founder-specific political overhangs than any company-fundamentals concern, meaning a rebound is plausible if those overhangs resolve. What to watch next: whether the stock stabilizes meaningfully above or below $135 over the coming weeks, and whether any pre-IPO SPV sponsors face LP redemption pressure tied to marking positions to the new public price.
